Drug Policy Executive Course – 2023

After the success of the Drug Policy Executive Course conducted in 2021-2022, the International Drug Policy Academy is now launching the second edition of this advance comprehensive course to be held in 2023. 

Drug Policy Executive Course is a three-module advanced course over a 12-month period, with in-person and distant learning components. The course will lead to a Certificate in Advance Drug Policy Management delivered by the International Drug Policy Academy. It is specially designed for managers or senior team members working in the area of drug policies and addictions. The Drug Policy Executive Course contains all key competency areas related to drug policy development, implementation, and evaluation.

The course aims to allow knowledge transfer among experienced professionals willing to expand their competences in this unique atmosphere.

If you are interested to be part of the graduates of this unique course – enrolment is open only till 15 November 2022. Should you have any questions or require further information, feel free in contacting the Secretariat at Pompidou.Academy@coe.int.

Reflections on the Constellations Festival

Correlation’s research officer Iga Jeziorska attended CONSTELLATIONS: An Online Festival on Drugs and Harm Reduction, offering insights and reflections from the 2 days of films, presentations, workshops and discussions.

During the festival, an update on the situation in Ukraine and activities of Polish harm reduction organisations supporting the refugee PWUD were discussed. The situation is difficult, but the harm reduction community works tirelessly. Despite the terrible context of the war, people remain motivated and services are working well. In Poland, unprecedented levels of unity and solidarity could be seen not only in harm reduction, but also in the society at large, when Polish citizens got highly mobilised to help Ukrainian neighbours fleeing from war.

Eurasian Harm Reduction Association [EHRA] has been operating a crowdfunding campaign to support Ukrainian PWUD and activitsts with individual financial support and humanitarian aid. If you are interested and able to support the cause, the bank details for donations are the following:

Name of account holder: Eurazijos žalos mažinimo asociacija

Purpose: Charitable donation for community in Ukraine

IBAN: LT92 7180 3000 0770 0220  

Bank name: AB Šiaulių bankas

BIC/SWIFT: CBSBLT26

The festival also featured two advocacy videos on drug consumption rooms by Drugreporter and INPUD:

Metzineres: From Survival to Fighting Back about Barcelona’s safe haven for womxn who use drugs and experience(d) violence. Metzineres offers a “full-spectrum” harm reduction approach, encouraging the dreams and passions of the womxn using their services to create a feeling of encouragement where the womxn can safely share stories and survival methods.

The second video was The Wall of Shame about the history of crack use in Paris and the need for opening a safe consumption site for people using it. The documentary explores the barriers in place preventing the development of a safe consumption space, and addresses the stigma and racial discrimination surrounding crack consumption in Paris.

The videos were followed by a very interesting discussion on the needs of PWUD, racial and sexual discrimination, and (in)effective policies.

The videos were followed by a session on arbitrary detention of marginalised groups, involving Dr Miriam Estrada-Castillo from the UN Working Group on Arbitrary Detention, who explained the methods of work of the group and encouraged to submit the appeals to the Working Group if experienced arbitrary detention. Interestingly, the Working Group works on the basis of the international human rights conventions (also, civil and social rights conventions, and Convention against Torture), with national codes being of little interest. Any person who experienced arbitrary detention (or their family or friends) can submit an appeal to the Working Group, regardless of the duration of the detention, the time that passed since a person was detained, or whether they are already free. If the Working Group confirms the arbitrariness of the detention, a person is entitled to financial compensation from the government. The Working Group’s decisions are legally binding. You can read more about the mandate and operation of the Group here.

Finally, there was a roundtable with Patriic Gayle and Leila Reid about chemsex harm reduction in Greater London, with storytelling on how the grassroots service Gay Men’s Health Collective has finally acquired funding, discussion on the specificity of work with people engaging in chemsex, and presentation of a harm reduction package, which will be distributed in the city in 20.000 copies very soon.

Webinar on New Drug Trends

On October 12 2022 at 16:00 CET we are delighted to be hosting a webinar on ‘Processes and Progress of Civil Society Monitoring of New Drugs Trends’.

This webinar will be the last of our monitoring webinar series which has explored the findings of our 2021 Data Report.

We are excited to share the final programme of the webinar with you;

Programme

  1. Welcome  |  Rafaela Rigoni [C-EHRN] [3 minutes]
  2. Presentation on the Progress of Monitoring New Drug Trends from a Civil Society perspective | Daan van de Gouwe [Trimbos Instituut]  [15 mins – 10 min presentation; 5  min Q & A with participants]
  3. Discussion Panel  | Lies Gremeaux [Sciensano]  |  Laura Smit Ritger [DIMS], Mireia Ventura [Energy Control], Tony Duffin [Ana Liffey], & Daan van de Gouwe [Trimbos Instituut]. Moderator: Rafaela Rigoni [C-EHRN] [25 mins]
  4. Q&A with participants [15 minutes]
  5. Closing remarks  |  Rafaela Rigoni [C-EHRN] [2 minutes]

Call for Youth Voices

Are you between 16 and 29 years old? Do you live in Europe or central Asia? For the #Youth4Health Tirana 2022 Health and Well-being Forum for Youth, we are calling young people to submit short clips.

We want to hear from you on the following questions:
Youth engagement
  • Why is it important to engage youth in health and well-being decision-making?
  • How would you ensure that youth is involved in decision-making to build a better, healthier future?
  • What do you want doctors and policymakers to know about young people’s health and well-being that they forget or often do not understand?
  • What else would you like to share?
Youth health 
  • What health issues matter most to you?
  • What inspires and enables you to look after your health and well-being?
COVID-19
  • How has the COVID-19 pandemic impacted on your life? 
  • What helped you to cope during the pandemic?
How to record:
  • Choose one question and record about 20-30 seconds 
  • Record with your phone or laptop in landscape format
  • You can submit videos for multiple questions
  • Please share in the highest resolution possible
Deadline: 18 September 2022
The clips will be shown at the #Youth4Health Tirana 2022 Youth and Well-being Forum, in Tirana (Albania) on 25-27 October 2022 and on WHO and its partners’ web and social media channels.

Feedback for Initiative on New Drug Precursors

The European Commission are requesting feedback for new drug precursors, looking to amend EU legislation to include new precursors used for illicit drug manufacturing.

New drug precursors have emerged and need to be added to EU legislation controlling these substances. That is the purpose of this initiative. Some of the new precursors were already added to the United Nations list at the 65th Commission on Narcotic Drugs.

The Commission would like to hear your views.
This draft act is open for feedback for 4 weeks. Feedback will be taken into account for finalising this initiative. Feedback received will be published on this site and therefore must adhere to the feedback rules.
Feedback period
02 September 2022 – 30 September 2022  (midnight Brussels time)

Rapid Assessment on Pre-exposure Prohylaxis (PrEP) in EU/EEA Countries

AIDS Action Europe is conducting a rapid assessment on the availability, accessibility, affordability, and acceptability of PrEP in the EU/EEA countries as part of their activities in their core thematic areas of sexual and reproductive health and rights (SRHR), affordability, and addressing legal and policy barriers to HIV services.

 
Based on the information provided from the survey, they are publishing a report on the main findings, and a policy brief with recommendations for the European Union and its Member States to support advocacy efforts, at the national and regional level towards universal access to PrEP. 
 

Please fill in this short survey to the best of your knowledge on the information from the EU/EEA country that you are based in.

 
The survey will be open until 31 August 2022.

 

Re-emergence of Injecting Cocaine Found in Ireland

The Syringe Analysis Pilot Project 2022 has identified a re-emergance of injecting cocaine, as well as the arrival of 3-Methylmethcathinone (3-MMC).

The Syrienge Analysis Pilot Project involves a collaboration between a laboratory and community services to analyse the current drug situation in Ireland and to inform health-led responses.

The pilot uses syrienge analysis to obtain information through the analysis of the content of used syrienges to help identify drug trends. The project obtained 155 used syrienges in order to conduct their research.

The significant re-emergance of injecting cociane was reported as being 86.5% in Dublin, and 89.1% in Midlands.

3-MMC was found to be present in 11.3% of Dublin syringes and 23.6% of Midlands ones. 3-MMC was only one of 32 different drugs and metabolites found in the syrienges tested in this pilot.

Harm Reduction International Abstract Submission Open

Abstract submission for HR23 is now open.

 

The theme for HR23 is Strength in Solidarity, with a particular interest in how harm reduction intersects with other social justice movements.

 

A list of starting point ideas includes;

  1. Indigenous, rural and underserved communities and harm reduction (particularly Aboriginal and Torres Strait Islander peoples’ priorities for harm reduction)
  2. Prisons/services/compulsory drug treatment/decarceration/abolition
  3. Harm reduction and covid-19 (community-led responses, access to vaccines, enforcement & human rights violations)
  4. Sex work and harm reduction
  5. Racism/white supremacy/decolonising drug policy
  6. Financing/funding harm reduction (sustainability and resilience in challenging environments/budget advocacy for harm reduction)
  7. Death penalty for drug offences
  8. Harm reduction as an ethic
  9. Children, young people and adolescents
  10. LGBTQI+ communities and harm reduction
  11. Traditional and medicinal use of drugs
  12. Current peer- and drug user-led services, programmes and organisations – advantages, challenges and history
  13. Progress in harm reduction (DCRs/overdose prevention/harm reduction for stimulant users/integrated services/intersections with mental health)
  14. Safer nightlife/party drug harm reduction/drug checking
  15. Feminism and harm reduction
  16. Harm reduction activism (successes/new strategies/social media tools)
  17. Drugs and pleasure: beyond harm reduction
  18. Harm reduction in crises (war/migration/humanitarian disasters/climate crisis/pandemics)
  19. Civil disobedience and harm reduction (illicit provision of naloxone/unsanctioned DCRs/safe supply)
  20. Tainted drug supplies/markets – their threat, and what they illustrate (E.g., fentanyl, benzo dope)

 

The call for abstracts will close at 23.59 BST on 30 September 2022.

 

More information, and how to apply here.

Production of Long Acting PrEP

ViiV have agreed to enable generic production of long acting PrEP to 90 countries.

ViiV and the Medicines Patent Pool have enabled access to generic formulation of long acting Cabotegravir for PrEP to 90 low- and lower-middle income countries.

This comes as progress in the global HIV response has slowed, and a rise in infections in many countries has been identified.

UNAIDS Deputy Executive a.i. Dr Matthew Kavanagh said;

“We urge all companies developing long-acting HIV medicines to commit to sharing technology through the Medicines Patent Pool, and all governments to act rapidly to secure affordable access to the newest technologies for all who would benefit from them. There must be no repeat by any company of the deadly delays in rolling out HIV products that we saw early on in the AIDS epidemic and that has recently been repeated with COVID-19 vaccines and therapeutics. Sharing technology is essential for stopping pandemics.”

 

Read the full announcement on the UNAIDS site here.

 

New UNAIDS Data on HIV Response During COVID-19

The data from UNAIDS of the global HIV response has shown that progress has faltered and resources have shrunk during the last two years of COVID-19 and other global crises.

As a result, millions of lives are now at risk. Communities that were already at a greater risk of HIV are now even more vulnerable due to an increase of 75 to 95 million people being pushed into poverty.

The data shows that the progress against HIV is slowing, with the smallest drop in new HIV cases being reported in 2020 since 2016.

 

 

The report also shows how UNAIDS responded to the unjust war in the Ukraine, with US$ 250 000 being disbursed to preserve key HIV services.

 

Read the full report here.